Susquehanna Financial Group analysts Meghna Ladha and James E Friedman maintain a Positive rating for iRobot Corporation (NASDAQ:IRBT) as the robotic company announce its financial results.
Roomba 880 launch in U.S. and international markets, strength in APAC and recovery in Europe should continue to support iRobot Corporation (NASDAQ:IRBT)’s growth momentum in 2014. We maintain our Positive rating and $40 price target.
Tiger Legatus Master Fund was up 0.1% net for the second quarter, compared to the MSCI World Index's 7.9% return and the S&P 500's 8.5% gain. For the first half of the year, Tiger Legatus is up 9%, while the MSCI World Index has gained 13.3%, and the S&P has returned 15.3%. Q2 2021 hedge Read More
iRobot Corporation (IRBT) earnings highlights
- 4Q revenue of $126.3 mln was modestly above our estimate; EPS beat by 2 cents at $0.11.
- 2014 guidance contemplates $560-$570 mln (15-17% Y/Y growth) in net revenue and EPS of $1.00-$1.15 (consensus at $1.11).
- Total home robot revenue increased 30.6% in 4Q and is expected to contribute $500-$515 mln in revenue (17-20% growth) in 2014.
- Domestic Home robot revenue increased 50% in 4Q thanks primarily to new product sales. International home robot revenue increased 18% with weakness in Europe offset by strength in APAC.
- iRobot Corporation (NASDAQ:IRBT) is seeing signs of recovery in Europe as macroeconomic headwinds subside and new products are rolled out (Braava).
- China contributed <$10 mln in revs in 2013.
- Next generation Roomba launch (800 series) has performed above expectations to date and the Scooba 450 is expected to roll out to new geographies in 2014.
- Reiterated long-term guidance through 2016 of mid-high teens revenue growth.
New distribution channels for home robots; Roomba 880 launch in stores in 1Q.
Downside risk for iRobot
Our downside risk of $33 is based on ~23x our forward EPS estimate, essentially in-line with its growth rate. We believe the stock could test such a level should iRobot Corporation (NASDAQ:IRBT) lose its leading position and fail to maintain double-digit growth in the home care robot segment. Additionally, a less effective S&M and slower product upgrade cycle could negatively impact profitability.